Potentially modifiable risk factors for adverse pregnancy outcomes in women with psoriasis

British Journal of Dermatology

Volumn 163, Issue 2, 2010, Pages 334-339

  Bandoli, G ^a   Johnson, D L ^a   Jones, K L ^a,b   Lopez Jiminez, J ^a   Salas, E ^a   Mirrasoul, N ^a   Van Voorhees, A S ^d   Chambers, C D ^a,b,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

depression; modifiable risk factors; obesity; pregnancy; psoriasis

Indexed keywords

ADULT; ADVERSE OUTCOME; ARTICLE; BODY MASS; COMORBIDITY; CONTROLLED STUDY; CROHN DISEASE; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; EDUCATIONAL STATUS; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OBESITY; ONSET AGE; PREGNANCY OUTCOME; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; QUALITY OF LIFE; RISK FACTOR; SMOKING; SOCIAL STATUS; VITAMIN SUPPLEMENTATION;

ADULT; AGE FACTORS; CANADA; COHORT STUDIES; DEPRESSION; DIETARY SUPPLEMENTS; FEMALE; HUMANS; OVERWEIGHT; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; PSORIASIS; RISK FACTORS; SMOKING; UNITED STATES;

EID: 77954869719     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09899.x     Document Type: Article

References (25)

1. Gelfand JM, Stern RS, Nijsten T et al. The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol 2005 52 : 23 6.
2. Levine D, Gottlieb A. Evaluation and management of psoriasis: an internist's guide. Med Clin North Am 2009 93 : 1291 1303.
3. Ben-David G, Sheiner E, Hallak M, Levy A. Pregnancy outcome in women with psoriasis. J Reprod Med 2008 53 : 183 187.
4. Schmitt J, Ford DE. Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based study. J Eur Acad Dermatol Venereol (in press).
5. Setty A, Curhan G, Choi H. Obesity, waist circumference, weight change, and the risk of psoriasis in women. Arch Intern Med 2007 167 : 1670 1675.
6. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995 32 : 982 986.
7. Huang YH, Yang LC, Hui RY et al. Relationships between obesity and the clinical severity of psoriasis in Taiwan. J Eur Acad Dermatol Venereol (in press).
8. Al-Mutairi N, Al-Farag S, Al-Mutairi A, Al-Shiltawy M. Comorbidities associated with psoriasis: an experience from the Middle East. J Dermatol 2010 37 : 146 155.
9. Waller DK, Shaw GM, Rasmussen SA et al. Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med 2007 161 : 745 750.
10. Hincz P, Borowski D, Krekora M et al. Maternal obesity as a perinatal risk factor. Ginekol Pol 2009 80 : 334 337.
11. Kashan A, Kenny L. The effects of maternal body mass index on pregnancy outcome. Eur J Epidemiol 2009 24 : 697 705.
12. Callaway LK, Prins JB, Chang AM, McIntyre HD. The prevalence and impact of overweight and obesity in an Australian obstetric population. Med J Aust 2006 184 : 56 9.
13. Chen M, McNiff C, Madan J et al. Maternal obesity and neonatal Apgar scores. J Matern Fetal Neonatal Med 2010 23 : 89 95.
14. Wisner KL, Sit DK, Hanusa BH et al. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry 2009 166 : 557 566.
15. Steer RA, Scholl TO, Hediger ML, Fischer RL. Self-reported depression and negative pregnancy outcomes. J Clin Epidemiol 1992 45 : 1093 1099.
16. Sugiura-Ogasawara M, Furukawa TA, Nakano Y et al. Depression as a potential causal factor in subsequent miscarriage in recurrent spontaneous aborters. Hum Reprod 2002 17 : 2580 2584.
17. Little J, Cardy A, Munger RG. Tobacco smoking and oral clefts: a meta-analysis. Bull World Health Organ 2004 82 : 213 218.
18. Rogers JM. Tobacco and pregnancy. Reprod Toxicol 2009 28 : 152 160.
19. Hollingshead AB. Four Factor Index of Social Status. Unpublished manuscript.
20. Takahashi H, Tsuji H, Takahashi I et al. Erratum to 'Prevalence of obesity/adiposity in Japanese psoriasis patients: adiposity is correlated with the severity of psoriasis'. J Dermatol Sci 2009 55 : 74 6.
21. Bardazzi F, Balestri R, Baldi E et al. Correlation between BMI and PASI in patients affected by moderate to severe psoriasis undergoing biological therapy. Dermatol Ther 2010 23 : S14 19.
22. Saraceno R, Schipani C, Mazzotta A et al. Effect of anti-tumor necrosis factor-α therapies on body mass index in patients with psoriasis. Pharmacol Res 2008 57 : 290 295.
23. Briot K, Gossec L, Kolta S et al. Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment. J Rheumatol 2008 35 : 855 861.
24. Prignano F, Ricceri F, Pescitelli L et al. Comparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biological therapies. Curr Med Res Opin 2009 25 : 2311 2316.
25. Gisondi P, Cotena C, Tessari G, Girolomoni G. Anti-tumor necrosis factor-α therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study. J Eur Acad Dermatol Venereol 2008 22 : 341 344.